Skip to main content

Table 3 Averaged antimicrobial resistance of the main Gram positive uropathogens for female and male patients

From: Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009)

Antimicrobials group

Antimicrobials

S. aureus

E. faecalis

S. epidermidis

  

N

%

M

F

N

%

M

F

N

%

M

F

Aminoglycosides

Amikacin

1104

5.5

5.8

5.4

336

5.1

1.3

6.2

Gentamicin

1116

6.2

7.3

5.9

652

31.7

35.6

30.3

337

5.6

7.7

5.0

Isepamicin

1023

5.4

5.5

5.3

447

62.9

67.2

61.2

314

1.3

0.0

1.6

Netilmicin

1094

3.3

4.3

3.0

336

1.5

0.0

1.9

Tobramycin

1107

6.4

8.1

5.9

335

6.6

9.0

5.8

Carbapenems

Imipenem

1106

2.1

3.9

1.5

672

6.3

5.2

6.7

336

0.0

0.0

0.0

Cephalosporins 1st G

Cefazolin

1097

15.6

22.0

13.6

324

12.0

10.5

12.5

Cephradine

1083

16.5

24.1*

14.2

 

334

12.3

11.7

12.5

Cephalosporins 2nd G

Cefoxitin

1097

16.6

20.2

15.5

337

13.1

9.1

14.2

Cefuroxime

1091

15.1

20.7

13.4

340

13.5

7.7

15.3

Cephalosporins 3rd G

Cefodizime

841

10.8

12.8

10.2

245

8.2

6.8

8.6

Ceftazidime

1084

17.1

19.0

16.5

336

18.8

11.7

20.8

Ceftibuten

1088

11.1

14.9

10.0

339

13.6

7.8

15.3

Cephalosporins 4th G

Cefepime

1086

10.7

14.2

9.6

338

11.8

9.1

12.6

Glycopeptides

Teicoplanin

827

3.1

4.4

2.7

621

4.0

5.7

3.4

233

0.9

0.0

1.1

Vancomycin

777

2.6

3.6

2.2

472

1.1

0.0

1.4

218

0.0

0.0

0.0

Nitrofurans

Nitrofurantoin

651

8.0

7.9

8.0

Penicillins

AMX-CLA

1107

8.3

15.1*

6.3

665

9.5

9.6

9.4

338

3.0

1.3

3.5

Flucloxacillin

992

16.8

20.3

15.8

304

15.8

12.3

16.9

Penicillin

1036

55.1

64.5

52.2

646

59.8

61.6

59.1

315

58.1

45.9

61.8

Quinolones

Ciprofloxacin

1103

18.0

33.3*

13.4

260

38.1

53.9*

31.5

331

26.6

32.9

24.8

Lomefloxacin

845

21.1

36.4*

15.8

206

45.1

58.9*

40.0

254

26.4

32.8

24.4

Norfloxacin

1073

18.3

32.9*

13.8

262

40.8

50.0

37.4

326

25.8

30.3

24.4

Ofloxacin

1091

17.8

31.9*

13.5

265

40.4

48.6

37.2

333

25.5

30.3

24.1

Sulfonamides

SxT

1075

15.6

22.4*

13.5

609

35.5

45.3*

31.6

328

25.9

29.7

24.8

  1. AMX - CLA Amoxicillin-clavulanic acid, SxT Trimethoprim-Sulfamethoxazole, n total number of bacteria resistant to each antimicrobial, N total number of bacteria tested against each antimicrobial; — Antimicrobial not tested, M male patient, F female patient, * statistically significant differences (p-value < 0.05) of antimicrobial resistance between female and male patients.